1. Home
  2. VRAX vs ULY Comparison

VRAX vs ULY Comparison

Compare VRAX & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • ULY
  • Stock Information
  • Founded
  • VRAX 2013
  • ULY 2013
  • Country
  • VRAX United Kingdom
  • ULY United States
  • Employees
  • VRAX N/A
  • ULY N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ULY
  • Sector
  • VRAX Health Care
  • ULY
  • Exchange
  • VRAX Nasdaq
  • ULY Nasdaq
  • Market Cap
  • VRAX 5.9M
  • ULY 6.0M
  • IPO Year
  • VRAX 2022
  • ULY N/A
  • Fundamental
  • Price
  • VRAX $1.08
  • ULY $7.37
  • Analyst Decision
  • VRAX Strong Buy
  • ULY Strong Buy
  • Analyst Count
  • VRAX 1
  • ULY 1
  • Target Price
  • VRAX $3.00
  • ULY $12.00
  • AVG Volume (30 Days)
  • VRAX 72.4K
  • ULY 363.5K
  • Earning Date
  • VRAX 02-05-2025
  • ULY 05-13-2025
  • Dividend Yield
  • VRAX N/A
  • ULY N/A
  • EPS Growth
  • VRAX N/A
  • ULY N/A
  • EPS
  • VRAX N/A
  • ULY N/A
  • Revenue
  • VRAX $84,872.00
  • ULY $134,085,000.00
  • Revenue This Year
  • VRAX $5,169.18
  • ULY N/A
  • Revenue Next Year
  • VRAX $66.97
  • ULY $17.87
  • P/E Ratio
  • VRAX N/A
  • ULY N/A
  • Revenue Growth
  • VRAX 7.03
  • ULY N/A
  • 52 Week Low
  • VRAX $0.65
  • ULY $2.99
  • 52 Week High
  • VRAX $9.00
  • ULY $32.04
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 51.25
  • ULY 47.27
  • Support Level
  • VRAX $1.03
  • ULY $4.54
  • Resistance Level
  • VRAX $1.20
  • ULY $11.80
  • Average True Range (ATR)
  • VRAX 0.07
  • ULY 2.45
  • MACD
  • VRAX 0.02
  • ULY -0.41
  • Stochastic Oscillator
  • VRAX 47.83
  • ULY 5.77

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

Share on Social Networks: